///Amnion & Bone Marrow MSCs

Amnion & Bone Marrow MSCs

Comparable osteogenic capacity of mesenchymal stem or stromal cells derived from human amnion membrane and bone marrow.

Abstract

So far, substantial attentions have been attracted to the application of mesenchymal stem or stromal cells (MSCs) in different therapeutic approaches. Although human bone marrow is commonly considered as a major source for MSCs, having an invasive collection method, ethical consideration and donor availability create a challenge for scientists, leading them to explore better alternative sources for MSCs. The study presented here aimed to characterize and compare osteogenic capacity of MSCs obtained from the amnion membrane (AM) with those originated from BM. Cells isolated from AMs and BMs were cultured in DMEM-low glucose supplemented with FBS, penicillin and streptomycin. After 24 h of incubation, cells adhered to the plastic surface of the flasks were allowed to proliferate for more days. A sub-confluent culture of cells was trypsinized and re-cultured. The MSCs were characterized by the expression of specific markers with flow cytometry. The osteogenic differentiation of MSCs was also validated by alkaline phosphatase and alizarian red S staining. Our results showed comparable expression of MSCs specific markers for both MSC sources (AM and BM). We also showed the optimum osteogenic differentiation of MSCs from both sources whereas hAM-MSCs revealed higher proliferation rate. We found no essential immunophenotypic differences between MSCs originated from bone marrow and amnion membrane while their differentiations into osteoblastic linage were also comparable. This was in addition to the higher proliferation rate observed for hAM-MSCs which suggests hAM as an easily accessible and reliable source of MSCs applicable for bone engineering, regenerative medicine or other therapeutic approaches.

By |2018-02-04T08:23:16+00:00February 4th, 2018|Blog|Comments Off on Amnion & Bone Marrow MSCs

FAQ:

PRP means Platelet Rich Plasma. The Plasma liquid in the blood includes red and white blood cells and platelets. Platelets form 10% of the plasma and in the concept of PRP, the platelet ratio is flipped to 90%. It is given in the form of an injection to patients looking to treat tissue damages, skin issues etc.
A non-surgical therapy in nature, PRP is used for healing in several medicine fields including sports medicines and orthopedics. PRP is nothing but the patient’s own blood which is administered in a way such that the healing components (growth factors) present in the platelets are released, thus fuelling fast recovery.
PRP is majorly useful in cases of soft tissue injuries, including ligament sprains, muscle pulls / tears, tendon tears, tendonitis and tendinosis. It has been an effective way to treat cartilage degeneration like arthritis as well.
With its methodology, PRP is developed to heal the injured region through the initiation of growth factors in your platelets. It is a cure and not just a temporary solution to limit any injury.
In most cases, the procedure can be well tolerated by patients but there may be soreness after the injection as PRP induces

CONTACT:

1340 Tully Rd #314
San Jose, CA 95122

866.704.8572

866.817.1181


New client pricing-

2 kits for $49!

prp-sidebar

Want to get in touch? Please do, we’d love to hear from you.

For general inquiries, you can fill out and submit your contact information. We also encourage you to call our offices directly at 866.704.8572 for the most current information.